New eye drop for pain passes first safety test in healthy volunteers
NCT ID NCT06978244
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-stage study tests a new eye drop called BL1332 in 24 healthy adults aged 18 to 50. The goal is to see if the drops are safe and tolerable, and to find the highest dose that can be given without causing serious side effects. This research is a first step toward possibly treating eye pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site 101
Fair Lawn, New Jersey, 07410, United States
Conditions
Explore the condition pages connected to this study.